Mark Mckenna

Mark Mckenna

Chairman presso APOGEE THERAPEUTICS, INC.

Patrimonio netto: 624 000 $ in data 31/03/2024

48 anni
Health Technology
Consumer Services

Profilo

Mark C.
Mckenna
is currently the Chairman at Apogee Therapeutics, Inc. and the Director at Spyre Therapeutics, Inc. He is also serving as a Director at Prometheus Laboratories, Inc. and as an Independent Director at Helix Acquisition Corp.
II.
Previously, he held the positions of Chairman, President & Chief Executive Officer at Prometheus Biosciences, Inc. from 2019 to 2023 and President at Salix Pharmaceuticals Ltd.
from 2016 to 2019.
Additionally, he worked as the Vice President & GM-Vision Care Division at Bausch & Lomb, Inc. from 2006 to 2016.
Mr. Mckenna obtained his undergraduate degree from Arizona State University and his MBA from Azusa Pacific University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
1.20%
08/02/2024 30 000 ( 1.20% ) 312 000 $ 31/03/2024
0.18%
09/02/2024 30 000 ( 0.18% ) 312 000 $ 31/03/2024
15/02/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Mark Mckenna

SocietàPosizioneInizio
APOGEE THERAPEUTICS, INC. Chairman 17/08/2023
SPYRE THERAPEUTICS, INC. Director/Board Member 01/02/2024
Director/Board Member -
Tutte le posizioni attive di Mark Mckenna

Precedenti posizioni note di Mark Mckenna

SocietàPosizioneFine
PROMETHEUS BIOSCIENCES, INC. Chief Executive Officer 16/06/2023
SALIX PHARMACEUTICALS, LTD. President 02/01/2019
Corporate Officer/Principal 02/01/2016
Director/Board Member -
Vedi nel dettaglio l'esperienza di Mark Mckenna

Formazione di Mark Mckenna

Arizona State University Undergraduate Degree
Azusa Pacific University Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark Mckenna

Relazioni

99

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SPYRE THERAPEUTICS, INC.

Health Technology

APOGEE THERAPEUTICS, INC.

Health Technology

Aziende private5

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Vedi le connessioni aziendali